- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Anteo Diagnostics Ltd (ADO)
Track the Anteo Diagnostics share price today and view real-time ADO share price data, including charts, technicals, and key financials. View the ADO premarket stock price ahead of the market session or assess the after hours quote. Explore ADO stock price movements, trading volume, and market activity across the ASX exchange.
What Is the Anteo Diagnostics Stock Price Today?
The Anteo Diagnostics stock price today is 0.041.
What Is the Stock Symbol for Anteo Diagnostics?
The stock symbol for Anteo Diagnostics is ""ADO.""
What Stock Exchange Does Anteo Diagnostics Trade On?
Anteo Diagnostics is listed and trades on the Sydney stock exchange.
Is Anteo Diagnostics a Good Stock to Buy?
Determining whether Anteo Diagnostics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADO quote. (ISIN: AU000000ADO8)
What Is the Anteo Diagnostics Stock Price Today?
The Anteo Diagnostics stock price today is 0.041.
What Is the Stock Symbol for Anteo Diagnostics?
The stock symbol for Anteo Diagnostics is ""ADO.""
What Stock Exchange Does Anteo Diagnostics Trade On?
Anteo Diagnostics is listed and trades on the Sydney stock exchange.
Is Anteo Diagnostics a Good Stock to Buy?
Determining whether Anteo Diagnostics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADO quote. (ISIN: AU000000ADO8)
Sydney
Currency in AUD
0.041
+0.009(+28.13%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.038
0.049
52 wk Range
0.007
0.049
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0380.049
52 wk Range
0.0070.049
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ADO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Anteo Diagnostics Ltd Earnings Call Summary for H1/2026
- AnteoTech raised AUD 3.5M in capital but stock held at 0.012 AUD, below raise price, amid revenue recognition delays with Serum Institute.
- Company restructured operations to cut costs and focus on core commercialization, eliminating non-essential activities across divisions.
- New product developments advanced in battery and life sciences sectors, though Wyon cell progress slower than anticipated for market entry.
- FY2026-2027 guidance shows zero EPS with revenue forecasts of USD 1.21 and USD 2.21 respectively; focus on sales conversion critical.
- Management acknowledged revenue timing challenges but emphasized strong financial position and commitment to expanding addressable markets.
Last Updated: 02/03/2026, 11:20 am
Read Full TranscriptEarnings
Latest Release
24/02/2026
EPS / Forecast
-- / --
Revenue / Forecast
96.77K / --
Compare ADO to Peers and Sector
Metrics to compare | ADO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.9x | −4.6x | 3.2x | |
PEG Ratio | −0.38 | 0.00 | 0.00 | |
Price/Book | 46.9x | 3.6x | 1.6x | |
Price / LTM Sales | 234.5x | 3.5x | 1.3x | |
Upside (Analyst Target) | 209.4% | 57.7% | 30.0% | |
Fair Value Upside | Unlock | −0.2% | 0.2% | Unlock |
AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development, and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. It also provides AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, the company offers contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
FAQ
What Is the Anteo Diagnostics (ADO) Stock Price Today?
The Anteo Diagnostics stock price today is 0.041 AUD.
What Stock Exchange Does Anteo Diagnostics Trade On?
Anteo Diagnostics is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Anteo Diagnostics?
The stock symbol for Anteo Diagnostics is "ADO."
What Is the Anteo Diagnostics Market Cap?
As of today, Anteo Diagnostics market cap is 115.950M AUD.
What Is Anteo Diagnostics's Earnings Per Share (TTM)?
The Anteo Diagnostics EPS (TTM) is -0.002.
From a Technical Analysis Perspective, Is ADO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Anteo Diagnostics Stock Split?
Anteo Diagnostics has split 6 times.
How Many Employees Does Anteo Diagnostics Have?
Anteo Diagnostics has 99 employees.
What is the current trading status of Anteo Diagnostics (ADO)?
As of 26/05/2026, Anteo Diagnostics (ADO) is trading at a price of 0.041 AUD, with a previous close of 0.032 AUD. The stock has fluctuated within a day range of 0.038 AUD to 0.049 AUD, while its 52-week range spans from 0.007 AUD to 0.049 AUD.
What Is Anteo Diagnostics (ADO) Price Target According to Analysts?
The average 12-month price target for Anteo Diagnostics is 0.099 AUD, with a high estimate of 0.099 AUD and a low estimate of 0.099 AUD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +141.46% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.